Edition:
United Kingdom

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,282.00GBp
15 Dec 2017
Change (% chg)

-6.00 (-0.47%)
Prev Close
1,288.00
Open
1,285.00
Day's High
1,287.00
Day's Low
1,272.00
Volume
6,278,127
Avg. Vol
3,701,684
52-wk High
1,442.00
52-wk Low
1,143.00

Chart for

About

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip... (more)

Overall

Beta: 0.84
Market Cap(Mil.): £12,228.70
Shares Outstanding(Mil.): 874.88
Dividend: 9.50
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.01 10.62
ROE: -- 16.85 14.20

BRIEF-Smith & Nephew announces acquisition of Rotation Medical Inc​

* ‍ACQUISITION COST IS $125 MILLION AND UP TO A FURTHER $85 MILLION OVER NEXT FIVE YEARS, CONTINGENT ON FINANCIAL PERFORMANCE​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

06 Dec 2017

Ex-ArthoCare CEO sentenced to 20 years in U.S. prison for fraud

The former chief executive of medical device company ArthroCare Corp was sentenced on Friday to 20 years in prison after being convicted of having orchestrated what federal prosecutors called a $750 million securities fraud.

03 Nov 2017

Ex-ArthoCare CEO sentenced to 20 years in U.S. prison for fraud

Nov 3 The former chief executive of medical device company ArthroCare Corp was sentenced on Friday to 20 years in prison after being convicted of having orchestrated what federal prosecutors called a $750 million securities fraud.

03 Nov 2017

Under pressure Smith & Nephew to focus on efficiency

LONDON Smith & Nephew said no major surgery is required for the artificial knee and hip maker to deliver shareholder value, even as it reported lacklustre sales that increase pressure on the company reportedly being stalked by activist investor Elliott.

03 Nov 2017

UPDATE 2-Under pressure Smith & Nephew to focus on efficiency

* Says full-year growth will be at lower end of 3-4 pct guidance

03 Nov 2017

BRIEF-S&N CEO will not confim if activist investor Elliott has stake

* Ceo says cost savings plan will be finalised by year-end results in feb

03 Nov 2017

Smith & Nephew sees full-year growth at lower end of guidance

LONDON, Nov 3 European hip and knee maker Smith & Nephew said on Friday its growth for the year would be at the lower end of its guidance after reporting a 3 percent rise in revenue for the third quarter, just missing average market expectations.

03 Nov 2017

Smith & Nephew to buy Rotation Medical for up to $210 million

LONDON Medical technology group Smith & Nephew , which some investors believe should streamline operations to make itself a more attractive takeover target, said on Monday it was buying a U.S. sports injury business for up to $210 million (£159 million).

23 Oct 2017

UPDATE 1-Smith & Nephew to buy Rotation Medical for up to $210 mln

LONDON, Oct 23 Medical technology group Smith & Nephew, which some investors believe should streamline operations to make itself a more attractive takeover target, said on Monday it was buying a U.S. sports injury business for up to $210 million.

23 Oct 2017

Smith & Nephew to buy Rotation Medical for up to $210 mln

LONDON, Oct 23 Medical technology group Smith & Nephew, which has been urged by activist investor Elliott Management to shed some operations according to media reports, has agreed to buy a U.S. tissue repair business for up to $210 million.

23 Oct 2017

Earnings vs. Estimates